Discontinuation of disease modifying therapies is associated with disability progression regardless of prior stable disease and age
Dejan Jakimovski, Katelyn Kavak, Caila B. Vaughn, Andrew Goodman, Patricia K. Coyle, Lauren Krupp, Malcolm Gottesman, Keith R. Edwards, Michael Lenihan, Allan Perel, Robert Zivadinov, Bianca Weinstock‐Guttman
Topics & Concepts
DiscontinuationMedicineExpanded Disability Status ScaleMultiple sclerosisInternal medicinePediatricsCohortDiseaseImmunologyMultiple Sclerosis Research StudiesAmyotrophic Lateral Sclerosis ResearchRheumatoid Arthritis Research and Therapies